Cancer-Fighting cell therapy tested against lupus and other autoimmune diseases

This early-stage study is testing whether a personalized cell therapy, similar to those used for some blood cancers, can help people with severe autoimmune diseases that haven't responded to standard treatments. Doctors will collect a patient's own immune cells, modify them to target a protein called CD19, and infuse them back to try to reset the faulty immune system. The main goals are to see if this approach is safe and shows any early signs of helping control diseases like lupus, scleroderma, and vasculitis.